|
Post by sellhighdrinklow on May 26, 2017 12:51:24 GMT -5
1,100 shares dropped it to $1.58!
|
|
|
Post by wgreystone on May 26, 2017 13:01:46 GMT -5
I am surprised that the soft script count didn't damp the SP.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 26, 2017 13:22:41 GMT -5
It did earlier.
|
|
|
Post by obamayoumama on May 26, 2017 13:33:21 GMT -5
I am surprised that the soft script count didn't damp the SP. Actually the dollar volume of sales increased over last week. Look at the dollar volume last week's numbers. Afrezza sales dollars could approach and pass peak sales when Sanofi was involved before this quarter is finished!
|
|
|
Post by lakon on May 26, 2017 13:56:46 GMT -5
It is nearing time to back up the truck. When the coiled spring releases, it will be unforgiven...
|
|
|
Post by slugworth008 on May 26, 2017 16:19:05 GMT -5
It is nearing time to back up the truck. When the coiled spring releases, it will be unforgiven... We still have a loooong way to go to overcome that 5/1 RS - I'll get excited when we clip past 15pps
|
|
|
Post by babaoriley on May 26, 2017 16:20:48 GMT -5
It is nearing time to back up the truck. When the coiled spring releases, it will be unforgiven... Lakon, when you say that, do you mean such time as whatever anticipated good news is released or before that? Something is driving this price, besides Sla and Sports' good looks (although MN's pithy remarks may also be helping). If that something happens, then we hope it is great and everyone will agree including shorts and new investors. If that something does not happen, well... So let me know how you play this.
|
|
|
Post by radgray68 on May 26, 2017 16:40:53 GMT -5
It's the sales dollars. QOQ & YOY increased sales are blood in the water on Wall Street. We seem to be at about roughly 10X sales currently. If we surpass Sanofi's best quarter by the end of this year, I, and others I presume, might start to feel validated for sticking around for so long. We'll still need funding, but a positive sales trajectory makes that a lot easier.
|
|
|
Post by dreamboatcruise on May 26, 2017 20:45:26 GMT -5
It's the sales dollars. QOQ & YOY increased sales are blood in the water on Wall Street. We seem to be at about roughly 10X sales currently. If we surpass Sanofi's best quarter by the end of this year, I, and others I presume, might start to feel validated for sticking around for so long. We'll still need funding, but a positive sales trajectory makes that a lot easier. If we make it until the end of the year we will have already gotten funding.
|
|
|
Post by mnkdfann on May 26, 2017 23:55:05 GMT -5
It is nearing time to back up the truck. When the coiled spring releases, it will be unforgiven... Lakon, when you say that, do you mean such time as whatever anticipated good news is released or before that? Something is driving this price, besides Sla and Sports' good looks (although MN's pithy remarks may also be helping). If that something happens, then we hope it is great and everyone will agree including shorts and new investors. If that something does not happen, well... I'm no market technician, but this move up reminds me of ONCYF's behaviour a few weeks back.
|
|
|
Post by lakon on May 27, 2017 12:12:45 GMT -5
It is nearing time to back up the truck. When the coiled spring releases, it will be unforgiven... Lakon, when you say that, do you mean such time as whatever anticipated good news is released or before that? Something is driving this price, besides Sla and Sports' good looks (although MN's pithy remarks may also be helping). If that something happens, then we hope it is great and everyone will agree including shorts and new investors. If that something does not happen, well... So let me know how you play this. Before the release would be ideal, but hard to time or even take the risk that dilution does not comes first. The safe play is to wait and buy into a squeeze after the news comes out IF it's good enough to change the dynamics. The big money goes to those who have the guts to be buying before the news -- more risk, more reward or pain.
|
|
|
Post by dreamboatcruise on May 27, 2017 21:41:54 GMT -5
Lakon, when you say that, do you mean such time as whatever anticipated good news is released or before that? Something is driving this price, besides Sla and Sports' good looks (although MN's pithy remarks may also be helping). If that something happens, then we hope it is great and everyone will agree including shorts and new investors. If that something does not happen, well... So let me know how you play this. Before the release would be ideal, but hard to time or even take the risk that dilution does not comes first. The safe play is to wait and buy into a squeeze after the news comes out IF it's good enough to change the dynamics. The big money goes to those who have the guts to be buying before the news -- more risk, more reward or pain. Consider an option strangle.
|
|
|
Post by cretin11 on May 28, 2017 17:11:17 GMT -5
What will the news be, in your opinion?
|
|
|
Post by lakon on May 29, 2017 3:38:51 GMT -5
Takes real guts to time a strangle. With MNKD, I have no idea WHEN they will achieve anything financially, but they have already achieved greatness scientifically. My opinion is that it is just a matter of time so I just keep buying to hold my position in the presence of dilution, r/s, etc. I do not think they will go bk, but can never rule it out completely. If MNKD can rule it out, the stock will move A LOT. My last options were LEAPS that "would never" assign. Well, I paid for that mistake... I'll keep buying shares at this point...I mean I took the assignment so why not... I expect an international deal, probably in Abu Dhabi or Qatar, and I expect more to follow after the first. The most logical move for MNKD is to focus on foreign nations that accept FDA approval, have high incidence of poorly treated PWD, and an unmet need. Islam allows for the use of needles when it is a medical necessity; however, there is a strong stigma against needle use. If there is an alternative, an argument can be made by the clerics that needles should not be used anymore. I expect that proof of better outcomes with Afrezza would essentially close the market to mealtime insulin injections throughout the Muslim world. It's the smart play for MNKD at this point. Ordinarily, many might consider these beliefs to be backward, but they can be useful. In light of the apparent corruption and lack of common sense in the West WRT Afrezza, MNKD should move into potentially friendlier markets to meet this unmet need. Japan would also be great, but the regulatory framework is more challenging there. I suspect that MNKD uses the MENA countries as a case study to demonstrate real world superiority to effectively embarrass the FDA as a side benefit to reduce future arguments. The move would improve cash flow. After real world evidence is undeniable, Japan would likely move in this direction for different, but similar, cultural reasons. The rest of Asia would follow suit. Somewhere along the way, and maybe first, I suspect that Israel will transition too. Finally, America and Europe will slowly change. The only wildcard is the push into this space by Silicon Valley, Amazon, One Drop, etc. The whole "Uber of Diabetes" for lack of a better descriptor should scare the Hell out of the incumbents, but it will take time due to the highly regulatory nature of the industry. That has to change, and perhaps, it gets Trumped by making the FDA impotent. We'll see. All that matters is better outcomes, and the FDA is NOT really effective at proving better outcomes, just selling a story that sounds good on the surface to all regulators and their proponents. If you are truly FREE, you do NOT want regulation. Don't get me wrong. I still think that MNKD remains focused on America and building its business in the USA. It remains a slow slog until they break thru the barriers to entry, and there are many more than I realized. America will remain the most profitable target market for some time so they have little choice. mnkd.proboards.com/thread/7143/mnkd-2017
|
|
|
Post by sportsrancho on May 29, 2017 5:53:13 GMT -5
I do not think they will go bk, but can never rule it out completely. If MNKD can rule it out, the stock will move a lot! -------------- Great post, agree with all! And when the market figures that out. Boom!
|
|